Field safety notices: Immundiagnostik
Group or brand name: several entities registered in EUDAMED may be concerned. The exact entity is named in each notice, at the source.
1 authority publication by one authority, from 23 Jul 2019 to 23 Jul 2019.
Latest notice: 23 Jul 2019, AEMPS, IDKmonitor® Infliximab total ADA. K 9654. IDKmonitor® Adalimumab total ADA. K 9651. Remsima® Monitor total ADA. K 9664. 25(OH)-Vitamin D direct day ELISA. K 2108. 25(OH)-Vitamin D dried blood ELISA. K 2108DBS. PreventID® Cardiac Troponin I. KSTCTI402
Uneven depth of sources: BfArM followed since March 2026, MHRA since January 2025, IGJ fully since 2026, BASG partial. The absence of a notice before these dates proves nothing. A notice repeated by several authorities appears once per authority. Independent page, neither published nor endorsed by Immundiagnostik or by any authority; a matching error can be reported through the legal notice page and is corrected within two working days.
1 distinct corrective action.
- IDKmonitor® Infliximab total ADA. K 9654. IDKmonitor® Adalimumab total ADA. K 9651. Remsima® Monitor total ADA. K 9664. 25(OH)-Vitamin D direct day ELISA. K 2108. 25(OH)-Vitamin D dried blood ELISA. K 2108DBS. PreventID® Cardiac Troponin I. KSTCTI402
Fuente: AEMPS (Agencia Española de Medicamentos y Productos Sanitarios), alertas de productos sanitarios · collected 17 Nov 2026